Register Login

Abiopharma

Home
About
Newsroom
Company List
Events
Automated Tools
Contact

News list

VIIV HLTHCARE

FDA Approval
Oct. 10, 2022, 01:37 UTC

FDA approve DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE

Full text

Register to leave comments
There are no comments here yet...

Search

News categories

Technical Exchange News(12342)

Event(6229)

SEC News(270218)

FDA Approval(10304)

Company Report(721)

Business News(157478)

© Copyright Abiopharma. All Rights Reserved

Designed by Alexey Vershinin